For the Inventor, By the Inventor

Enter assignee name

Santa Monica, CA, United States of America

Agensys, Inc.

USPTO Granted Patents = 196

CIPO Patents = 13

EPO Patents = 31

Trademarks = 7

Forward Citations = 1,296

Loading Chart...

Loading Chart...

60 inventors (with patents filed for the assignee):

Arthur B Raitano (158 out of 164 patents)

Aya Jakobovits (151 out of 189 patents)

Pia M Challita-Eid (113 out of 113 patents)

4. Rene S Hubert (110 out of 116 patents)

5. Mary Faris (99 out of 104 patents)

6. Wangmao Ge (68 out of 68 patents)

7. Karen Jane Meyrick Morrison (66 out of 66 patents)

8. Robert Kendall Morrison (62 out of 62 patents)

9. Daniel E H Afar (55 out of 56 patents)

10. Douglas C Saffran (34 out of 41 patents)

11. Jean M Gudas (33 out of 49 patents)

12. Xiao-Chi Jia (26 out of 57 patents)

13. Daniel E Afar (25 out of 36 patents)

14. Juan J Perez-Villar (23 out of 26 patents)

15. Steve Chappell Mitchell (22 out of 22 patents)

Core Competencies:

Antibody Drug Conjugates

AXL Proteins

CD37 Proteins

FLT3 Proteins

STEAP-1 Proteins

Nucleic Acid Molecules

Prostate Stem Cell Antigen

Tumor Associated Proteins

Cancer Detection

Dolaproine-Dolaisoleucine Peptides

Nectin-4 Binding Proteins

Serpentine Transmembrane Antigens

196 patents: Sort by Forward Citations

1. 12257340 - Pharmaceutical compositions comprising anti-191P4D12 antibody drug conjugates and methods of use thereof (2025-03-25),

2. 11739155 - Antibodies that bind to AXL proteins (2023-08-29),

3. 11718677 - Antibodies that bind to AXL proteins (2023-08-08),

4. 11634503 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2023-04-25),

5. 11633500 - Antibody drug conjugates (ADC) that bind to CD37 proteins (2023-04-25),

6. 11559582 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2023-01-24),

7. 11401347 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2022-08-02),

8. 11312748 - Derivatives of dolaproine-dolaisoleucine peptides (2022-04-26),

9. 11292837 - Nectin-4 binding proteins and methods of use thereof (2022-04-05),

10. 10894090 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-19),

11. RE48389 - Antibody drug conjugates (ADC) that bind to 191P4D12 proteins (2021-01-11),

12. 10787517 - Antibodies that bind to AXL proteins (2020-09-29),

13. 10787516 - Antibodies that bind to AXL proteins (2020-09-29),

14. 10751422 - Antibody drug conjugates (ADC) that bind to FLT3 proteins (2020-08-25),

15. 10669348 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2020-06-02),

AGENSYS, INC. is a global technology solutions company that specializes in providing innovative software and consulting services. With a focus on digital transformation, artificial intelligence, and data analytics, AGENSYS helps businesses leverage technology to drive growth, efficiency, and customer satisfaction. Our team of experienced professionals works closely with clients to understand their unique requirements and deliver tailored solutions. Visit our website to learn more about our services and explore our success stories.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

196 Patents

#4 in Santa Monica, CA

#473 in California

#2,032 in US

#4,186 in the World

Santa Monica, CA, United States of America

Agensys, Inc.

Forward Citations = 1,296

60 inventors:

Arthur B Raitano (158 out of 164 patents)

Aya Jakobovits (151 out of 189 patents)

Pia M Challita-Eid (113 out of 113 patents)

4. Rene S Hubert (110 out of 116 patents)

5. Mary Faris (99 out of 104 patents)

Please report any incorrect information to support@idiyas.com

Loading…